Gail Colbern
- Biomaterials top 1%
- Nanoparticle-Based Drug Delivery 7
- Equine top 5%
- Veterinary Equine Medical Research 4
- Pharmaceutical Science top 5%
- Oncology top 10%
- HER2/EGFR in Cancer Research 4
- Molecular Biology top 10%
- RNA Interference and Gene Delivery 3
- Glycosylation and Glycoproteins Research 2
-
- Monoclonal and Polyclonal Antibodies Research 4
-
- Reproductive Physiology in Livestock 3
-
- Reproductive System and Pregnancy 3
- Co-authors
- Peter K. WorkingMichael AmanteaJohn W. ParkDemetrios PapahadjopoulosChristopher C. BenzDmitri B. KirpotinRefaat ShalabyKeelung Hong
- Journals
- Journal of Liposome Research (4 papers)Journal of Equine Veterinary Science (3 papers)Cancer Chemotherapy and Pharmacology (3 papers)
- Partner nations
- United StatesNetherlandsIsrael
In The Last Decade
Gail Colbern
20 papers receiving 1.4k citations
Hit Papers
Peers
Comparison fields: 5 of 95
- Biomaterials 795
- Equine 29
- Pharmaceutical Science 69
- Oncology 310
- Molecular Biology 707
Countries citing papers authored by Gail Colbern
This map shows the geographic impact of Gail Colbern's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gail Colbern with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gail Colbern more than expected).
Fields of papers citing papers by Gail Colbern
This network shows the impact of papers produced by Gail Colbern. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gail Colbern. The network helps show where Gail Colbern may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Gail Colbern, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | IAP (inhibitor of apoptosis) antagonist inhibits orthotopic lung tumor growth | 2007 | 1 |
| 2 | 2005 | 22 | |
| 3 | 2004 | 60 | |
| 4 | 2004 | 133 | |
| 5 | 2004 | 153 | |
| 6 | Anti-HER2 Immunoliposomes | 2002 | 10 |
| 7 | Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery.breakdown → | 2002 | 518 |
| 8 | 2002 | 69 | |
| 9 | 2000 | 6 | |
| 10 | 1999 | 40 | |
| 11 | 1999 | 239 | |
| 12 | 1999 | 25 | |
| 13 | 1998 | 15 | |
| 14 | 1997 | 24 | |
| 15 | 1994 | 86 | |
| 16 | 1994 | 16 | |
| 17 | 1987 | 13 | |
| 18 | 1987 | 9 | |
| 19 | 1987 | 7 | |
| 20 | 1984 | 5 |
About Gail Colbern
Gail Colbern is a scholar working on Equine, Biomaterials, Agronomy and Crop Science, Small Animals and Oncology, having authored 20 papers that have together received 1.5k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (7 papers), Veterinary Equine Medical Research (4 papers), HER2/EGFR in Cancer Research (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Reproductive Physiology in Livestock (3 papers), RNA Interference and Gene Delivery (3 papers), Reproductive System and Pregnancy (3 papers) and Glycosylation and Glycoproteins Research (2 papers). The work is most often cited by research in Biomaterials (795 citations), Equine (29 citations), Pharmaceutical Science (69 citations), Oncology (310 citations) and Molecular Biology (707 citations). Gail Colbern has collaborated with scholars based in United States, Netherlands and Israel. Frequent co-authors include Peter K. Working, Michael Amantea, John W. Park, Demetrios Papahadjopoulos, Christopher C. Benz, Dmitri B. Kirpotin, Refaat Shalaby, Keelung Hong, Charles Engbers and Mary S. Newman. Their work appears in journals such as Journal of Liposome Research, Journal of Equine Veterinary Science, Cancer Chemotherapy and Pharmacology, Clinical Cancer Research and Seminars in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.